SK284826B6 - 7-Nitro-9-substituovaný amino-6-demetyl-6-deoxytetracyklíny a spôsoby ich výroby - Google Patents

7-Nitro-9-substituovaný amino-6-demetyl-6-deoxytetracyklíny a spôsoby ich výroby Download PDF

Info

Publication number
SK284826B6
SK284826B6 SK1149-99A SK114999A SK284826B6 SK 284826 B6 SK284826 B6 SK 284826B6 SK 114999 A SK114999 A SK 114999A SK 284826 B6 SK284826 B6 SK 284826B6
Authority
SK
Slovakia
Prior art keywords
group
alkyl
amino
carbon atoms
substituted
Prior art date
Application number
SK1149-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK114999A3 (en
Inventor
Joseph J. Hlavka
Phaid-Eng Sum
Yakov Gluzman
Ving J. Lee
Adma A. Ross
Original Assignee
Wyeth Holdings Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25092264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284826(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Holdings Corporation filed Critical Wyeth Holdings Corporation
Publication of SK114999A3 publication Critical patent/SK114999A3/sk
Publication of SK284826B6 publication Critical patent/SK284826B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/44Naphthacenes; Hydrogenated naphthacenes
    • C07C2603/461,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Moulding By Coating Moulds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK1149-99A 1991-10-04 1992-09-30 7-Nitro-9-substituovaný amino-6-demetyl-6-deoxytetracyklíny a spôsoby ich výroby SK284826B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77157691A 1991-10-04 1991-10-04

Publications (2)

Publication Number Publication Date
SK114999A3 SK114999A3 (en) 2000-07-11
SK284826B6 true SK284826B6 (sk) 2005-12-01

Family

ID=25092264

Family Applications (2)

Application Number Title Priority Date Filing Date
SK1149-99A SK284826B6 (sk) 1991-10-04 1992-09-30 7-Nitro-9-substituovaný amino-6-demetyl-6-deoxytetracyklíny a spôsoby ich výroby
SK2984-92A SK280837B6 (sk) 1991-10-04 1992-09-30 Tricyklické diazepíny, spôsob ich výroby, ich použitie a farmaceutický prípravok na ich báze

Family Applications After (1)

Application Number Title Priority Date Filing Date
SK2984-92A SK280837B6 (sk) 1991-10-04 1992-09-30 Tricyklické diazepíny, spôsob ich výroby, ich použitie a farmaceutický prípravok na ich báze

Country Status (28)

Country Link
EP (1) EP0536515B1 (pl)
JP (1) JP3186863B2 (pl)
KR (1) KR100269072B1 (pl)
CN (1) CN1048240C (pl)
AT (1) ATE211128T1 (pl)
AU (1) AU654049B2 (pl)
BR (1) BR1100853A (pl)
CA (1) CA2079692C (pl)
CL (1) CL2004001623A1 (pl)
CZ (2) CZ284159B6 (pl)
DE (4) DE122006000058I1 (pl)
DK (1) DK0536515T3 (pl)
ES (1) ES2168254T3 (pl)
FI (1) FI114911B (pl)
HK (1) HK1011348A1 (pl)
HU (2) HU219973B (pl)
IL (3) IL103320A (pl)
LU (1) LU91279I2 (pl)
MX (1) MX9205532A (pl)
NL (1) NL300244I2 (pl)
NO (3) NO301472B1 (pl)
NZ (1) NZ244585A (pl)
PL (4) PL175957B1 (pl)
PT (1) PT536515E (pl)
SG (1) SG52361A1 (pl)
SK (2) SK284826B6 (pl)
TW (1) TW275616B (pl)
ZA (1) ZA927607B (pl)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420272A (en) * 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) * 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
WO1995022529A1 (en) * 1994-02-17 1995-08-24 Pfizer Inc. 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US8106225B2 (en) 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
CN102336680A (zh) 1999-09-14 2012-02-01 塔夫茨大学信托人 用基于过渡金属的化学制备取代四环素的方法
ES2288945T3 (es) * 2000-03-31 2008-02-01 Trustees Of Tufts College Compuestos de tetraciclina 7 y 9-carbamato, urea, tiourea, tiocarbamato y heteroaril-amino sustituidos.
WO2001087824A2 (en) * 2000-05-15 2001-11-22 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
EP1679305B1 (en) * 2000-07-07 2012-02-08 Trustees Of Tufts College 9-Substituted minocycline compounds
US7094806B2 (en) 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
EP1368305B1 (en) 2001-03-13 2008-08-13 Paratek Pharmaceuticals, Inc. 7, 9-substituted tetracycline compounds
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP1241160A1 (en) 2001-03-13 2002-09-18 Glaxo Group Limited Tetracycline derivatives and their use as antibiotic agents
AU2002250331A1 (en) 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
JP2004529927A (ja) * 2001-04-24 2004-09-30 パラテック ファーマシューティカルズ, インク. マラリアの治療のための置換されたテトラサイクリン化合物
EP2329826A1 (en) 2001-07-13 2011-06-08 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of multiple sclerosis
AU2002365120A1 (en) 2001-08-02 2003-07-15 Paratek Pharmaceuticals, Inc. Medicaments
EP2311799A1 (en) 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
IL163931A0 (en) * 2002-03-08 2005-12-18 Paratek Pharm Innc Amino-methyl substituted tetracyline compounds
AU2004259659B2 (en) 2003-07-09 2011-11-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
UA83266C2 (en) * 2003-12-08 2008-06-25 Уайет Oxazole derivatives of tetracyclines
BR122018069604B1 (pt) * 2004-05-21 2021-07-20 President And Fellows Of Harvard College Compostos de tetraciclinas e análogos das mesmas, uso dos referidos compostos, composição farmacêutica, bem como métodos de sintetização e de preparação dos referidos compostos
US7534766B2 (en) 2004-11-05 2009-05-19 Wyeth Glucuronide metabolites and epimers thereof of tigecycline
AR057649A1 (es) 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
JP2009507793A (ja) * 2005-08-31 2009-02-26 ワイス グリシルサイクリンの9−アミノカルボニル置換誘導体
EP2431469A3 (en) 2006-05-15 2012-05-30 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
MY153749A (en) 2007-11-29 2015-03-13 Actelion Pharmaceuticals Ltd Phosphonic acid derivates and their use as p2y12 receptor antagonists
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
ITMI20080807A1 (it) 2008-05-05 2009-11-06 Antibioticos Spa Procedimento per la preparazione di tigeciclina in forma amorfa
TWI585071B (zh) 2008-05-23 2017-06-01 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
CN105367440A (zh) * 2008-08-08 2016-03-02 四相制药公司 C7-氟取代的四环素化合物
US9073829B2 (en) 2009-04-30 2015-07-07 President And Fellows Of Harvard College Synthesis of tetracyclines and intermediates thereto
DK2427425T3 (en) 2009-05-08 2017-06-12 Tetraphase Pharmaceuticals Inc tetracycline
NO2470500T3 (pl) * 2009-08-28 2018-03-03
MX347919B (es) 2010-05-12 2017-05-17 Rempex Pharmaceuticals Inc * Composiciones de tetraciclina.
CN103635456B (zh) * 2011-07-26 2016-03-09 山东亨利医药科技有限责任公司 替加环素衍生物
SI2890673T1 (sl) 2012-08-31 2019-05-31 Tetraphase Pharmaceuticals, Inc. Spojine tetraciklina
WO2015071299A2 (en) 2013-11-12 2015-05-21 Galenicum Health S.L. Stable pharmaceutical compositions
SG11201903327PA (en) 2016-10-19 2019-05-30 Tetraphase Pharmaceuticals Inc Crystalline forms of eravacycline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338963A (en) * 1960-10-28 1967-08-29 American Cyanamid Co Tetracycline compounds
US3579579A (en) * 1968-04-18 1971-05-18 American Cyanamid Co Substituted 7- and/or 9-amino-6-demethyl-6-deoxytetracyclines

Also Published As

Publication number Publication date
CA2079692C (en) 2004-06-08
CZ309397A3 (cs) 1998-09-16
PT536515E (pt) 2002-05-31
NO2006015I2 (no) 2011-03-14
IL103320A0 (en) 1993-03-15
IL119590A0 (en) 1997-02-18
CN1048240C (zh) 2000-01-12
LU91279I2 (fr) 2006-12-11
KR100269072B1 (ko) 2000-10-16
CZ284209B6 (cs) 1998-09-16
KR930007894A (ko) 1993-05-20
FI924454A (fi) 1993-04-05
CZ284159B6 (cs) 1998-08-12
EP0536515A1 (en) 1993-04-14
PL175957B1 (pl) 1999-03-31
ZA927607B (en) 1993-04-13
NO923857L (no) 1993-04-05
CA2079692A1 (en) 1993-04-05
MX9205532A (es) 1993-04-01
BR1100853A (pt) 1999-12-07
TW275616B (pl) 1996-05-11
ES2168254T3 (es) 2002-06-16
DE69232302T4 (de) 2003-02-13
SK114999A3 (en) 2000-07-11
DE69232302T2 (de) 2002-08-14
JP3186863B2 (ja) 2001-07-11
NL300244I1 (nl) 2007-01-02
CN1072172A (zh) 1993-05-19
SG52361A1 (en) 1998-09-28
PL172282B1 (pl) 1997-08-29
DE122006000058I2 (de) 2007-09-13
NO2006015I1 (no) 2006-11-27
CL2004001623A1 (es) 2005-06-03
SK298492A3 (en) 1995-03-08
SK280837B6 (sk) 2000-08-14
DK0536515T3 (da) 2002-04-08
PL176333B1 (pl) 1999-05-31
HU9203110D0 (en) 1992-12-28
HU211172A9 (en) 1995-11-28
FI924454A0 (fi) 1992-10-02
HK1011348A1 (en) 1999-07-09
NO301472B1 (no) 1997-11-03
ATE211128T1 (de) 2002-01-15
NO2017037I2 (no) 2017-08-01
IL119590A (en) 1999-03-12
PL173311B1 (pl) 1998-02-27
NO923857D0 (no) 1992-10-02
HU219973B (hu) 2001-10-28
JPH05255219A (ja) 1993-10-05
AU2618392A (en) 1993-04-08
DE122006000058I1 (de) 2007-01-18
NZ244585A (en) 1995-07-26
HUT63145A (en) 1993-07-28
IL103320A (en) 1998-12-06
DE69232302D1 (de) 2002-01-31
EP0536515B1 (en) 2001-12-19
NO2017037I1 (no) 2017-08-01
NL300244I2 (nl) 2007-01-02
AU654049B2 (en) 1994-10-20
FI114911B (fi) 2005-01-31
CZ298492A3 (en) 1993-05-12
PL296143A1 (en) 1993-05-31

Similar Documents

Publication Publication Date Title
SK284826B6 (sk) 7-Nitro-9-substituovaný amino-6-demetyl-6-deoxytetracyklíny a spôsoby ich výroby
USRE40086E1 (en) Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines
US5834450A (en) 9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics
US5281628A (en) 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines
JP3639313B2 (ja) 新規な7−(置換)−8−(置換)−9−(置換アミノ)−6−デメチル−6−デオキシテトラシクリン類
US20130029943A1 (en) Methods of Preparing Substituted Tetracyclines with Transition Metal-Based Chemistries
US20040033996A1 (en) Methods of preparing substituted tetracyclines with transition metal-based chemistries
AU2003220123A1 (en) Amino-methyl substituted tetracycline compounds
USRE40183E1 (en) 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
WO2003079983A2 (en) Methods of preparing substituted tetracyclines with transition metal-based chemistries
HU212267B (en) Process for preparing 9-nitro-7-(substituted)-6-demethyl-6-desoxytetracyclin derivatives

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20120930